By Counterforce Health Team in Carbaglu (carglumic acid) —

How to Get Carbaglu (Carglumic Acid) Covered by Aetna CVS Health in Virginia: Appeals Guide and Templates

Answer Box: Fast Track to Carbaglu Coverage

Carbaglu (carglumic acid) is covered by Aetna CVS Health in Virginia for FDA-approved NAGS deficiency with prior authorization. To get approved:

  1. Submit PA request with genetic/biochemical confirmation of NAGS deficiency plus elevated plasma ammonia labs
  2. If denied, file internal appeal within 180 days using medical necessity documentation
  3. Virginia residents can request external review using Form 216-A within 120 days of final denial

Start today: Contact your prescriber to gather diagnostic test results and baseline ammonia levels for the PA submission.

Table of Contents

Understanding Aetna CVS Health Coverage for Carbaglu

Aetna CVS Health covers Carbaglu (carglumic acid) for specific FDA-approved indications, but prior authorization is required. Here's what you need to know:

Coverage at a Glance

Requirement Details Documentation Needed
Covered Indications NAGS deficiency (acute/chronic hyperammonemia); Propionic/Methylmalonic acidemia Genetic or biochemical test results
Prior Authorization Required for all uses Elevated plasma ammonia + confirmed diagnosis
Initial Approval 12 months if criteria met Complete diagnostic workup
Reauthorization Annual with proof of benefit Lab results showing reduced ammonia
Non-covered Uses Off-label uses considered experimental Not applicable

Important: Carbaglu is handled through CVS Specialty Pharmacy for most Aetna plans, which provides dedicated support for rare disease medications.

Reading Your Denial Letter

When Aetna CVS Health denies Carbaglu, the letter will specify the reason. Common denial codes include:

  • Medical necessity not established: Missing diagnostic confirmation
  • Experimental/investigational: Off-label use or insufficient evidence
  • Prior authorization incomplete: Missing required documentation
  • Step therapy required: Must try alternative treatments first
Tip: Your denial letter includes critical appeal deadlines—typically 180 days for internal appeals. Mark this date immediately.

Fixable Issues Before Appealing

Before filing a formal appeal, check if these common issues can be resolved:

Missing Documentation Checklist

  • Genetic testing results confirming NAGS deficiency
  • Baseline plasma ammonia levels (elevated)
  • Complete medical history and diagnosis codes
  • Provider attestation of medical necessity
  • Prior treatment failures (if applicable)

Quick Fixes

  1. Contact CVS Specialty at the number on your denial letter to verify what documentation is missing
  2. Request peer-to-peer review if the denial seems based on misunderstanding of the case
  3. Check formulary status to ensure Carbaglu wasn't moved to a different tier

First-Level Internal Appeal

Aetna CVS Health provides multiple levels of internal review before you need external help.

Step-by-Step Appeal Process

  1. Gather Evidence (1-2 days)
    • Medical records showing NAGS deficiency diagnosis
    • Lab results with elevated ammonia levels
    • FDA label information for Carbaglu
    • Clinical guidelines supporting use
  2. Draft Medical Necessity Letter (see template below)
    • Patient demographics and diagnosis
    • Clinical rationale for Carbaglu
    • Evidence of medical necessity
    • Monitoring plan
  3. Submit Appeal (same day)
    • Use Aetna member portal or provider portal
    • Include all supporting documentation
    • Request expedited review if clinically urgent
  4. Track Timeline
    • Standard appeals: 30-45 days
    • Expedited appeals: ≤72 hours for urgent cases

Peer-to-Peer Review Strategy

A peer-to-peer review allows your prescribing physician to speak directly with an Aetna medical director.

Preparation Checklist for Your Doctor

  • Patient's complete clinical history
  • Diagnostic test results confirming NAGS deficiency
  • Current ammonia levels and trends
  • Treatment goals and monitoring plan
  • FDA labeling information for Carbaglu

Key Talking Points

  • FDA indication: Carbaglu is specifically approved for NAGS deficiency
  • Unique mechanism: Only available N-acetylglutamate analog
  • Life-threatening condition: Hyperammonemia can cause brain damage
  • No alternatives: Limited treatment options for this rare condition

Virginia External Review Process

Virginia residents have strong protections through the State Corporation Commission Bureau of Insurance external review process.

Eligibility Requirements

  • Completed Aetna's internal appeal process
  • Denial based on medical necessity, experimental treatment, or similar clinical judgment
  • Virginia-issued health plan or opted-in self-funded plan

Filing Process

  1. Download Form 216-A from Virginia SCC
  2. Complete within 120 days of final internal denial
  3. Attach denial letter (do not include medical records initially)
  4. Submit to Virginia Bureau of Insurance

Timeline Expectations

  • Standard Review: 45 days for IRO decision
  • Expedited Review: 72 hours for urgent cases (requires Form 216-C from provider)
  • IRO Decision: Final and binding on insurer
Note: Contact the Bureau at 1-877-310-6560 for guidance before submitting your external review request.

Medical Necessity Letter Template

Here's a framework your physician can use:

[Date]
[Aetna Medical Director]
[Address from denial letter]

RE: Medical Necessity Appeal for Carbaglu (carglumic acid)
Member: [Name], ID: [Number]

Dear Medical Director,

I am writing to appeal the denial of Carbaglu (carglumic acid) for my patient, [Name], who has genetically confirmed N-acetylglutamate synthase (NAGS) deficiency.

CLINICAL BACKGROUND
[Patient name] is a [age]-year-old with NAGS deficiency confirmed by [genetic testing/enzyme assay] on [date]. Baseline plasma ammonia levels were elevated at [value] μmol/L (normal <50).

FDA INDICATION
Carbaglu is FDA-approved for acute and chronic hyperammonemia due to NAGS deficiency. This is the only available treatment that directly addresses the underlying enzyme deficiency by providing N-acetylglutamate analog activity.

MEDICAL NECESSITY
Without treatment, hyperammonemia poses significant risk of neurological damage and death. Carbaglu has demonstrated efficacy in normalizing ammonia levels in NAGS deficiency patients.

MONITORING PLAN
We will monitor plasma ammonia levels every [frequency] and adjust dosing as needed to maintain levels within normal range.

I respectfully request approval for Carbaglu as medically necessary treatment for this FDA-approved indication.

Sincerely,
[Physician name and credentials]
[License number]

Tracking and Escalation

Appeal Log Template

Date Action Contact Outcome Next Step
[Date] PA submitted CVS Specialty Pending Wait 30 days
[Date] Denial received - Denied for [reason] File appeal
[Date] Internal appeal filed Aetna Pending Track deadline

When to Escalate

Contact Virginia regulators if:

  • Aetna fails to respond within stated timelines
  • Appeals process seems unfair or biased
  • You suspect violations of state insurance law

Virginia Bureau of Insurance: 1-877-310-6560 or [email protected]

Patient Assistance Programs

While pursuing coverage, explore financial assistance:

Carbaglu Support Programs

  • Carbaglu Copay Support Program: $0 copay for qualified commercially insured patients
  • Patient Assistance Program: Free medication for uninsured/underinsured patients
  • CVS Specialty CareTeam: Navigation support and financial assistance connections

Application Process

  1. Contact Accredo (Carbaglu Support Program administrator)
  2. Complete financial assistance application
  3. Provide insurance information and income documentation
  4. Receive approval and enrollment instructions
From our advocates: "We've seen patients successfully combine manufacturer assistance with insurance coverage appeals. Even if your appeal is pending, apply for patient assistance programs immediately—there's often no waiting period, and you can maintain therapy while fighting the denial."

When Appeals Fail: Next Steps

If all appeals are unsuccessful, consider:

Alternative Strategies

  1. Formulary exception request for non-formulary status
  2. Step therapy override if alternatives are required first
  3. Provider-administered option through medical benefit vs. pharmacy benefit
  4. Clinical trial enrollment if available and appropriate
  • Virginia Poverty Law Center: Health assistance for low-income patients
  • Patient advocacy organizations: Rare disease foundations may provide legal guidance
  • Healthcare attorneys: For complex cases involving potential insurance violations

FAQ

How long does Aetna CVS Health prior authorization take in Virginia? Standard PA decisions take 30-45 days. Expedited reviews for urgent cases are completed within 72 hours.

What if Carbaglu is non-formulary on my plan? You can request a formulary exception with medical necessity documentation. Non-formulary doesn't mean non-covered if medically necessary.

Can I request expedited appeal in Virginia? Yes, if your doctor certifies that delay could seriously jeopardize your health. Use Form 216-C for Virginia external review.

Does step therapy apply to Carbaglu? Typically no, since Carbaglu has a unique mechanism for NAGS deficiency. However, some plans may require documentation of why alternatives aren't appropriate.

What happens if I miss the appeal deadline? Contact Aetna immediately to request deadline extension based on good cause. Virginia may allow late external review filing in exceptional circumstances.

How much does Carbaglu cost without insurance? Cash prices can exceed $200 per 200mg tablet. Monthly costs vary significantly based on weight-based dosing requirements.

About Counterforce Health

Counterforce Health helps patients, clinicians, and specialty pharmacies turn insurance denials into successful appeals. Our platform analyzes denial letters and plan policies to create targeted, evidence-backed appeals that address the specific reasons for denial. For medications like Carbaglu, we help identify the right clinical documentation and regulatory citations needed to demonstrate medical necessity according to each payer's own criteria.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Always consult with your healthcare provider and insurance plan for specific coverage decisions. Insurance policies and state regulations may change; verify current requirements with official sources before taking action.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.